Abstract
Peptide deformylase (PDF) catalyzes the removal of the N-terminal formyl group from newly synthesized polypeptides in eubacteria. Its essential role in bacterial cells but not in mammalian cells makes it an attractive target for antibacterial drug design. We have previously reported an N-formylhydroxylamine-based, metal-chelating macrocyclic PDF inhibitor, in which the P(1)' and P(3)' side chains are covalently joined. In this work, we have carried out a structure-activity relationship study on the size of the macrocycle and found that 15-17-membered macrocycles are optimal for binding to the PDF active site. Unlike the acyclic compounds, which are simple competitive inhibitors, the cyclic compounds all act as slow-binding inhibitors. As compared to their acyclic counterparts, the cyclic inhibitors displayed 20-50-fold higher potency against the PDF active site (K(I) as low as 70 pM), improved selectivity toward PDF, and improved the metabolic stability in rat plasma. Some of the macrocyclic inhibitors had potent, broad spectrum antibacterial activity against clinically significant Gram-positive and Gram-negative pathogens. These results suggest that the macrocyclic scaffold provides an excellent lead for the development of a n...Continue Reading
References
Dec 1, 1994·Journal of Bacteriology·T Meinnel, S Blanquet
Jan 1, 1993·Biochimie·T MeinnelS Blanquet
Jan 1, 1997·Analytical Biochemistry·C Lazennec, T Meinnel
Jul 1, 1997·Journal of Computer-aided Molecular Design·C McMartin, R S Bohacek
Jun 4, 1998·Biochemical and Biophysical Research Communications·D GrocheA F Wagner
Apr 9, 1999·Biochemistry·T MeinnelS Blanquet
Jun 22, 1999·Journal of Molecular Biology·S RagusaT Meinnel
Apr 12, 2000·Biochemistry·K M HuntingtonD Pei
Jul 6, 2000·Journal of Medicinal Chemistry·C ApfelJ L Specklin
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·J M ClementsM G Hunter
Sep 8, 2001·Drug Discovery Today·Z YuanR J. White
Feb 14, 2004·The Journal of Antimicrobial Chemotherapy·M GrossK W Johnson
Feb 28, 2004·The Journal of Organic Chemistry·Reed A CoatsMichael H Howard
Citations
Nov 8, 2012·ACS Chemical Biology·Ziqing QianDehua Pei
Dec 26, 2012·ACS Combinatorial Science·Amit ThakkarDehua Pei
Jun 6, 2007·Journal of Medicinal Chemistry·Qing Xiao, Dehua Pei
Mar 9, 2011·Journal of Medicinal Chemistry·Eric Marsault, Mark L Peterson
Jun 22, 2010·Journal of Medicinal Chemistry·Takashi YamamotoVictor J Hruby
Jul 2, 2008·Nature Reviews. Drug Discovery·Edward M DriggersNicholas K Terrett
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Monica Fonseca-AtenR Doug Hardy
Oct 27, 2009·PLoS Computational Biology·Wesley C Van VoorhisLance J Stewart
Nov 20, 2009·Biochimica Et Biophysica Acta·Alexander K BergD K Srivastava
Aug 5, 2008·Drug Discovery Today·Matteo Colombo, Ilaria Peretto
Aug 30, 2005·Current Opinion in Microbiology·John F Barrett
Feb 7, 2006·Biochemical Pharmacology·Molly B Schmid
Aug 26, 2014·European Journal of Medicinal Chemistry·Shouning YangWenhao Hu
Oct 21, 2016·Scientific Reports·Sonia FieulaineCarmela Giglione
Mar 24, 2016·Chemistry : a European Journal·Anniefer N MagpusaoMark W Peczuh
Nov 6, 2007·Archives of Biochemistry and Biophysics·Kiet T NguyenDehua Pei
Jul 21, 2017·Journal of Chemical Information and Modeling·Dan SindhikaraShana L Posy
Nov 20, 2018·Chembiochem : a European Journal of Chemical Biology·Xiaohong TanBruce A Armitage
Jan 6, 2007·Organic & Biomolecular Chemistry·Fa LiuTerrence R Burke
Aug 4, 2009·PloS One·Laurent MamelliJean-Marie Pagès
May 29, 2015·Proteomics·Willy V BienvenutThierry Meinnel
Apr 2, 2020·Materials·Hao LiRoser Pleixats
Feb 24, 2011·Chemistry : a European Journal·Raquel ÁlvarezRafael Peláez
Feb 23, 2021·Frontiers in Chemistry·Angela DailingAlessandra Luchini
Sep 19, 2009·Bioorganic & Medicinal Chemistry·Takashi YamamotoVictor J Hruby
Jun 1, 2010·Bioorganic & Medicinal Chemistry Letters·Wei ShiWenhao Hu